"Clinical Trials has operated in the Triad area for over 15 years. Dedicated medical team with paid clinical trial participation opportunities in Asthma, Diabetes, Gout, Alzheimer's Disease, COVID Prevention, Constipation, Adult ADHD, Dementia, Neuropathy, NASH, RSV Vaccines and many others."

During the past decade, Triad Clinical Trials conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 13 clinical trials were completed, i.e. on average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Triad Clinical Trials" #1 sponsor was "Allergan" with 4 trials, followed by "Iroko Pharmaceuticals, LLC" with 3 trials sponsored, "Selecta Biosciences, Inc." with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "AstraZeneca" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Triad Clinical Trials" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Triad Clinical Trials" are "Gastroparesis" (4 trials), "Osteoarthritis" (4 trials), "Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Triad Clinical Trials" in a lesser frequency.

Most popular intervention types in "Triad Clinical Trials" are "Drug" (23 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Relamorelin" (3 trials), "Diclofenac" (2 trials), "Alum" (1 trials) and "CAD106 Immunotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Triad Clinical Trials" are 22 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Triad Clinical Trials". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Triad Clinical Trials, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Triad Clinical Trials, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".